题名

Salivary Duct Carcinoma of the Submandibular Gland: A Rare Case Report and Review of Literature

并列篇名

下頷腺的唾液腺管道癌:罕見病例報告及文獻回顧

作者

Nan-Tsung Wang(王南宗);Ching-Jung Wu(吳錦榕);Suzun Shaw(蕭世禎)

关键词

Radiotherapy ; Salivary duct carcinoma ; Submandibular gland ; 放射線治療 ; 唾液腺管道癌 ; 下頷腺

期刊名称

醫學與健康期刊

卷期/出版年月

12卷3期(2023 / 11 / 01)

页次

73 - 80

内容语文

英文;繁體中文

中文摘要

Salivary ductal carcinoma (SDC) is a salivary gland malignancy that is highly aggressive with a poor prognosis, but it is extremely rare. The tumor cells resemble invasive ductal carcinoma of the breast pathologically. The authors describe herein a case of high-grade salivary duct carcinoma arising from the submandibular gland. The patient was a 63-year-old male who had a firm mass around the right submandibular region. Microscopic examination showed intraductal proliferation of salivary duct-type epithelium with a comedo-type necrosis pattern. Immunohistochemical analysis revealed an abnormal increase of CK7 and EMA in tumor cells. The overall features were most comparable with those of high-grade salivary duct carcinoma. After undergoing submandibulectomy and adjuvant radiotherapy (RT), the patient developed multiple distant metastases within two years. We found adjuvant radiotherapy alone after operation seemed to be insufficient. The necessity of systemic treatment should also be considered.

英文摘要

唾液腺管道癌是一種罕見但具高度侵犯性的惡性腫瘤。此腫瘤細胞病理型態上與侵襲性乳管癌相似。作者在此報告一名長在下頷腺之唾液腺管道癌病例。這位63歲男性發現在右側下頷腺處有一腫塊。手術後顯微檢查發現唾液腺管腔上皮增生伴有粉刺型壞死。免疫組織化學染色呈現CK7與EMA異常增加。綜合以上發現與高度惡性唾液腺管道癌最相符合。病患在接受下頷腺切除術後也做了輔助性放射線治療,但卻在兩年之內發生了腫瘤遠處轉移。因此我們發現手術後加做輔助性放射線治療似乎是不夠的。全身性治療的必要性也需要納入考慮。

主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. Colmenero Ruiz, C,Patron Romero, M,Martin Perez, M(1993).Salivary duct carcinoma: a report of nine cases.J Oral Maxillofac Surg,51,641-646.
  2. Gilbert, MR,Sharma, A,Schmitt, NC(2016).A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.AMA Otolaryngol Head Neck Surg,142,489-495.
  3. Gondak, RO,Mariano, FV,Alves, FA,Almeida, OP,Lopes, MA(2014).Salivary duct carcinoma in minor salivary glands: report of two cases with different clinical behavior.J Clin Exp Pathol,4,1-6.
  4. Halperin, EC(ed.),Perez, CA(ed.),Brady, LW(ed.)(2004).Principles and Practice of Radiation Oncology.Philadelphia:Lippincott Williams & Wilkins.
  5. Jaehne, M,Roeser, K,Jaekel, T,Schepers, JD,Albert, N,Loning, T(2005).Clinical and immunohistologic typing of salivary duct carcinoma: A report of 50 cases.Cancer,103,2526-2533.
  6. Jalaly, JB,Sanati, S,Chernock, RD,Dibe, DG,El-Mofty, SK(2018).Salivary duct carcinoma and invasive ductal carcinoma of the breast: A comparative immunohistochemical study.Head Neck Pathol,12,488-492.
  7. Johnston, ML,Huang, SH,Waldron, JN(2016).Salivary duct carcinoma: Treatment, outcomes, and patterns of failure.Head Neck,8,820-826.
  8. Kaidar-Person, O,Billan, S,Kuten, A(2012).Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review.Med Oncol,29,704-706.
  9. Kawahara, K,Hiraki, A,Yoshida, R(2017).Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report.Molecular and clinical oncology,6,886-892.
  10. Kleinsasser, O,Klein, HJ,Hubner, G(1968).Salivary duct carcinoma: a group of salivary gland tumors analogous to mammary duct carcinoma.Arch Klin Exp Ohren Nasen Kehlkopfheilkd,192,100-105.
  11. McHugh, JB,Visscher, DW,Barnes, EL(2009).Update on selected salivary gland neoplasms.Arch Pathol Lab Med,133,1763-1774.
  12. Mukaigawa, T,Hayashi, R,Hashimoto, K,Toru, U,Naohito, H,Satoshi, F(2016).Programmed death ligand-1 expression is associated with poor disease-free survival in salivary gland carcinomas.J Surg Oncol,114,36-43.
  13. Salovaara, E,Hakala, O,Back, L(2013).Management and outcome of salivary duct carcinoma in major salivary glands.Eur Arch Otorhinolaryngol,270,281-285.
  14. Shinoto, M,Shioyama, Y,Nakamura, K(2013).Postoperative radiotherapy in patients with salivary duct carcinoma: Clinical outcomes and prognostic factors.J Radiat Res,54,925-930.
  15. Simpson, RH(2013).Salivary duct carcinoma: new development smorphological variants including pure in situ high grade lesions; proposed molecular classification.Head Neck Pathol,7,48-58.
  16. The AACR Project GENIE Consortium(2017).AACR Project GENIE: powering precision medicine through an international consortium.Cancer Discovery,7,818-831.
  17. Xie, S,Yang, H,Bredell, M(2015).Salivary duct carcinoma of the parotid gland: A case report and review of the literature.Oncology letters,9,371-374.
  18. Zainab, H,Sultana, A,Jahagirdar, P(2017).Denovo High Grade Salivary Duct Carcinoma: A Case Report and Review of Literature.Journal of clinical and diagnostic research: JCDR,11,10.
  19. Zhu, S,Schuerch, C,Hunt, J(2015).Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors.Arch Pathol Lab Med,139,55-66.